Therapeutic effect of sarpogrelate, a new 5-hydroxytryptamine receptor 2a antagonist, on diabetic nephropathy and neuropathy

Nephron

Volumn 76, Issue 2, 1997, Pages 227-229

  Ishimura, Eiji ^a   Nishizawa, Yoshiki ^a   Emoto, Masanori ^a   Slioji, Tetsuo ^a   Inaba, Masaaki ^a   Kawagishi, Takahiko ^a   Morii, Hirotoshi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; SARPOGRELATE; SEROTONIN; SEROTONIN ANTAGONIST; TRANSFERRIN;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DRUG EFFICACY; FEMALE; HUMAN; LETTER; MALE; MICROCIRCULATION; PERIPHERAL VASCULAR SYSTEM; PRIORITY JOURNAL; PROTEINURIA;

ADULT; AGED; ALBUMINURIA; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; SUCCINATES; TIME FACTORS;

EID: 0030943094     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190175     Document Type: Article

References (11)

1. Hoyer D, Clarke DE, Fozard JR., Ilarlig PR, Martin OR: International Union of Pharmacology classification of receptors for 5-hydroxy-tryptamine (serotonin)., Pharmacol Rev 1994: 46:157-203.
2. Kikumoto R., Hara H., Ninomiya K., Osakabe M, Sugano M., Futami H, Tamao Y: Synthesis and platelet aggregation inhibitory and antithrombotic properties of (2-0-aminoalkvl) phenylethylbenzenes., J Med Chem 1990:33: 1818-1823.
3. Nebigil CG., Garnovskava MN., Spurney RF., Raymond JR: Identification of a rat glomerular mesangial cell mitogenic 5-HT:A receptor., Am J Physiol 1995:268:F122-F127.
4. Knauss T, Abboud HE: Effect of serotonin on prostaglandin synthesis in rat cultured mesangial cells., Am J Physiol 1986:251:F844-F850.
5. Takuwa N., Ganz M., Takuwa Y., Stcrzel RB, Rasmussen H: Studies of the mitogenic effect of serotonin by rat renal mesangial cells., Am J Physiol 1989;257:F431-F439.
6. Ardaillou R., Ronco P, Rondeau E: Biology of renal cell in culture; in Brenner BM (ed): The Kidney., Philadelphia., Saunders Co., 1996., pp 99-192.
7. Dyck PJ: Hypoxic neuropathy: Does hypoxia play a role in diabetic neuropathy? Neurology 1989:39:111-118.
8. Yasuda H., Dyck PJ: Abnormalities of endo-neurial microvessels and sural nerve pathology in diabetic neuropathy., Neurology 1987:37: 20-28.
9. Magnotti RAJ., Eberly JP., Khoury PR., Daniels SR., Drozda DJ., Turner AM, Dolan EM: Profile of renal permselectivity by simultaneous enzyme-linked immunosorbent assay of albumin, transferrin., IgG and 1q-microglobulin with a new microplatc reader., Clin Chem 1992; 38:636-641.
10. Barradas MA., Gill DS., Fonseca VA., Mikhail-idis DR., Dandona P: Intraplatelet serotonin in patients with diabetes mellitus and peripheral vascular disease., Eur J Clin Invest 1988:18: 399-404.
11. Malvszko J., Urano T., Knoller R., Taminato A., Yoshimi T, Takada Y., Takada A: Daily variations of platelet aggregation in relation to blood and plasma serotonin in diabetes., Thromb Res 1994:75:569-576